// App-Quantinova.ai

e19031 : Pre-cancer cardiovascular risk factors and anthracycline-related cardiotoxicity among non-Hodgkin lymphoma survivors.

Researchers

Presenter

  • Talya Salz

Principal Investigators

  • Peter Brown

  • Emily Craig Zabor

  • Susanne Oksbjerg Dalton

  • Nirupa Jaya Raghunathan

  • Matthew J. Matasar

  • Richard Steingart

  • Andrew J. Vickers

  • Kevin C. Oeffinger

  • Christoffer Johansen

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • H:S Rigshospitalet, The Finsen Centre, KAT, Haematology Department 4241, Copenhagen, Denmark

  • Survivorship, Danish Cancer Society, Copenhagen, Denmark

  • Institute of Cancer Epidemiology, Copenhagen O, Denmark

Locations

  • United States

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ischemic stroke

  • Coronary Artery Disease

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Cardiotoxicity

  • Heart muscle disease

  • Dyslipidemia

  • Hypertension

  • Lymphomas

  • Diabetes

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved